FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Supplemental Application (ScieGen Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for a fixed-dose combination of amlodipine and olmesartan medoxomil from ScieGen Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine and olmesartan medoxomil (amlodipine and olmesartan medoxomil)

Snippet

SUPPL AP for AMLODIPINE AND OLMESARTAN MEDOXOMIL (AMLODIPINE AND OLMESARTAN MEDOXOMIL)